In our study, the mRNA expression and enzymatic activity of CDA in CML and AL patients remarkably increased compared with those in the donors of hematopoietic stem cell transplantation. The gene discussed is CDA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.